Evaluate the Efficacy and Safety of Orelabrutinib in Adult Patients With Systemic Lupus Erythematosus

Clinical trial NCT05688696 · RECRUITING

Trial details

NCT number: NCT05688696
Sponsor: Beijing InnoCare Pharma Tech Co., Ltd.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Systemic Lupus Erythematosus, SLE

Start date: 2023-04-29
Primary completion: 2025-08-25
Enrollment: 186

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.